These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 17970038)
1. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease. Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 trans-signaling in inflammatory bowel disease. Mitsuyama K; Sata M; Rose-John S Cytokine Growth Factor Rev; 2006 Dec; 17(6):451-61. PubMed ID: 17045835 [TBL] [Abstract][Full Text] [Related]
3. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717 [TBL] [Abstract][Full Text] [Related]
4. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS Mol Immunol; 2010 Sep; 47(15):2467-74. PubMed ID: 20615550 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Rose-John S; Scheller J; Elson G; Jones SA J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558 [TBL] [Abstract][Full Text] [Related]
6. No inhibition of IL-27 signaling by soluble gp130. Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scheller J; Ohnesorge N; Rose-John S Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis. Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542 [TBL] [Abstract][Full Text] [Related]
9. IL-6 signal transduction and its physiological roles: the signal orchestration model. Kamimura D; Ishihara K; Hirano T Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404 [TBL] [Abstract][Full Text] [Related]
10. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing. Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726 [TBL] [Abstract][Full Text] [Related]
11. Capsaicin inhibits the IL-6/STAT3 pathway by depleting intracellular gp130 pools through endoplasmic reticulum stress. Lee HK; Seo IA; Shin YK; Park JW; Suh DJ; Park HT Biochem Biophys Res Commun; 2009 May; 382(2):445-50. PubMed ID: 19285962 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971 [TBL] [Abstract][Full Text] [Related]
14. The regenerative activity of interleukin-6. Galun E; Rose-John S Methods Mol Biol; 2013; 982():59-77. PubMed ID: 23456862 [TBL] [Abstract][Full Text] [Related]
15. IL-6 transsignaling: the in vivo consequences. Jones SA; Richards PJ; Scheller J; Rose-John S J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T J Exp Med; 2006 Jun; 203(6):1459-70. PubMed ID: 16717113 [TBL] [Abstract][Full Text] [Related]
17. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver. Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237 [TBL] [Abstract][Full Text] [Related]
18. Teleost IL-6 promotes antibody production through STAT3 signaling via IL-6R and gp130. Kaneda M; Odaka T; Suetake H; Tahara D; Miyadai T Dev Comp Immunol; 2012 Oct; 38(2):224-31. PubMed ID: 22469658 [TBL] [Abstract][Full Text] [Related]
19. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991 [TBL] [Abstract][Full Text] [Related]
20. Cell type-specific STAT3 activation by gp130-related cytokines in the peripheral nerves. Wang L; Lee HK; Seo IA; Shin YK; Lee KY; Park HT Neuroreport; 2009 May; 20(7):663-8. PubMed ID: 19349921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]